SE7510988L - Nya farmaceutiskt aktiva foreningar - Google Patents

Nya farmaceutiskt aktiva foreningar

Info

Publication number
SE7510988L
SE7510988L SE7510988A SE7510988A SE7510988L SE 7510988 L SE7510988 L SE 7510988L SE 7510988 A SE7510988 A SE 7510988A SE 7510988 A SE7510988 A SE 7510988A SE 7510988 L SE7510988 L SE 7510988L
Authority
SE
Sweden
Prior art keywords
pharmaceutical active
new pharmaceutical
active associations
associations
new
Prior art date
Application number
SE7510988A
Other languages
English (en)
Inventor
L A Svensson
L M Sorenby
K I L Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE7510988A priority Critical patent/SE7510988L/sv
Priority to ZA765331A priority patent/ZA765331B/xx
Priority to DE19762640972 priority patent/DE2640972A1/de
Priority to AT682376A priority patent/AT347427B/de
Priority to FI762660A priority patent/FI762660A/fi
Priority to SU762402852A priority patent/SU638252A3/ru
Priority to NZ182165A priority patent/NZ182165A/xx
Priority to AU18122/76A priority patent/AU503212B2/en
Priority to DD195022A priority patent/DD126278A5/xx
Priority to NO763345A priority patent/NO763345L/no
Priority to DK439776AA priority patent/DK141622B/da
Priority to ES451979A priority patent/ES451979A1/es
Priority to NL7610845A priority patent/NL7610845A/xx
Priority to FR7629467A priority patent/FR2326183A1/fr
Priority to LU75916A priority patent/LU75916A1/xx
Priority to GB7640684A priority patent/GB1542317A/en
Priority to CS766357A priority patent/CS199643B2/cs
Priority to JP51118924A priority patent/JPS5242840A/ja
Priority to CS782253A priority patent/CS199644B2/cs
Priority to BE171148A priority patent/BE846837A/xx
Publication of SE7510988L publication Critical patent/SE7510988L/sv
Priority to SU772532454A priority patent/SU674669A3/ru
Priority to AT108278A priority patent/AT350526B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7510988A 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar SE7510988L (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar
ZA765331A ZA765331B (en) 1975-10-01 1976-09-07 Novel pharmaceutically active compounds
DE19762640972 DE2640972A1 (de) 1975-10-01 1976-09-11 Aminoaethanolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT682376A AT347427B (de) 1975-10-01 1976-09-15 Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen
FI762660A FI762660A (sv) 1975-10-01 1976-09-16
SU762402852A SU638252A3 (ru) 1975-10-01 1976-09-22 Способ получени производных аминоэтанола или их солей
NZ182165A NZ182165A (en) 1975-10-01 1976-09-27 Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition
AU18122/76A AU503212B2 (en) 1975-10-01 1976-09-27 1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their esters
DD195022A DD126278A5 (sv) 1975-10-01 1976-09-28
ES451979A ES451979A1 (es) 1975-10-01 1976-09-30 Un metodo de preparacion de compuestos antialergicos.
DK439776AA DK141622B (da) 1975-10-01 1976-09-30 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-(3,5-dihydroxyfenyl)-2-aminoætanolderivater eller syreadditionssalte deraf.
NO763345A NO763345L (sv) 1975-10-01 1976-09-30
NL7610845A NL7610845A (nl) 1975-10-01 1976-09-30 Nieuwe farmacologisch werkzame verbindingen.
FR7629467A FR2326183A1 (fr) 1975-10-01 1976-09-30 Composes et compositions a activite antiallergique et antianaphylactique
LU75916A LU75916A1 (sv) 1975-10-01 1976-09-30
GB7640684A GB1542317A (en) 1975-10-01 1976-09-30 Phenylethanolamine derivatives
CS766357A CS199643B2 (en) 1975-10-01 1976-10-01 Method of producing novel derivatives of phenylaminoethanol
JP51118924A JPS5242840A (en) 1975-10-01 1976-10-01 Novel pharmaceutically active compound
CS782253A CS199644B2 (en) 1975-10-01 1976-10-01 Method of producing new derivatives of phenylaminoethanol
BE171148A BE846837A (fr) 1975-10-01 1976-10-01 Composes et compositions a activite antiallergique et anti-anaphylactique,
SU772532454A SU674669A3 (ru) 1975-10-01 1977-10-13 Способ получени производных этанола или их солей
AT108278A AT350526B (de) 1975-10-01 1978-02-15 Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen -(1) und von deren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
SE7510988L true SE7510988L (sv) 1977-04-02

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Country Status (19)

Country Link
JP (1) JPS5242840A (sv)
AT (1) AT347427B (sv)
AU (1) AU503212B2 (sv)
BE (1) BE846837A (sv)
CS (2) CS199644B2 (sv)
DD (1) DD126278A5 (sv)
DE (1) DE2640972A1 (sv)
DK (1) DK141622B (sv)
ES (1) ES451979A1 (sv)
FI (1) FI762660A (sv)
FR (1) FR2326183A1 (sv)
GB (1) GB1542317A (sv)
LU (1) LU75916A1 (sv)
NL (1) NL7610845A (sv)
NO (1) NO763345L (sv)
NZ (1) NZ182165A (sv)
SE (1) SE7510988L (sv)
SU (2) SU638252A3 (sv)
ZA (1) ZA765331B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1273A (en) 1980-07-09 1985-03-08 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
EP2189448B1 (en) * 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Processes for the Separation of 3-Benzazepine Racemates
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
ES2704455T3 (es) 2010-09-01 2019-03-18 Arena Pharm Inc Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
CS199643B2 (en) 1980-07-31
NL7610845A (nl) 1977-04-05
SU674669A3 (ru) 1979-07-15
GB1542317A (en) 1979-03-14
AT347427B (de) 1978-12-27
SU638252A3 (ru) 1978-12-15
AU1812276A (en) 1978-04-06
DD126278A5 (sv) 1977-07-06
DE2640972A1 (de) 1977-04-14
ATA682376A (de) 1978-05-15
LU75916A1 (sv) 1978-05-16
BE846837A (fr) 1977-04-01
AU503212B2 (en) 1979-08-30
JPS5242840A (en) 1977-04-04
FR2326183A1 (fr) 1977-04-29
DK141622B (da) 1980-05-12
FI762660A (sv) 1977-04-02
ES451979A1 (es) 1978-01-01
DK439776A (sv) 1977-04-02
CS199644B2 (en) 1980-07-31
NZ182165A (en) 1978-07-10
ZA765331B (en) 1977-08-31
NO763345L (sv) 1977-04-04

Similar Documents

Publication Publication Date Title
SE7605620L (sv) Farmakologiskt aktiva foreningar
SE7612366L (sv) Nya hydroxibensylmalonsyra-derivat.
SE7604761L (sv) Nya polypeptider
SE7614085L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7710762L (sv) Farmakologiskt aktiva foreningar
SE7600139L (sv) Nya vifenyloxiderivat
SE7510988L (sv) Nya farmaceutiskt aktiva foreningar
SE408266B (sv) Narkosmedelavdunstare
SE7506947L (sv) Farmakologiskt aktiva foreningar
FI56525B (fi) Nya kromogena trombinsubstrat
SE7702771L (sv) Farmakologiskt aktiva foreningar
SE7608478L (sv) Farmaceutica
FR2326189A2 (fr) Composition pharmaceutique
SE7703948L (sv) Nya anibakteriella foreningar
SE7603563L (sv) Nya tiazolinoner
SE7606877L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7605158L (sv) Nya organiska foreningar
SE7705857L (sv) Farmaceutiskt aktiva foreningar
SE7612565L (sv) Forfarande for framstellning av nya rifamycinforeningar
SE7605818L (sv) Nya diureidforeningar
SE7606405L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7506348L (sv) Hjertaktiva foreningar
SE7600480L (sv) Farmaceutiskt anvendbara 2-aminoacetamido-alfa-fenylbensylidenaminoalk
FR2320731A1 (fr) Composition pharmaceutique
BE840608A (fr) Nouvelles compositions pharmaceutiques